

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 6.91491045 |
| 2 | muscle filament sliding (GO:0030049) | 6.40869417 |
| 3 | actin-myosin filament sliding (GO:0033275) | 6.40869417 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.01062112 |
| 5 | cardiac myofibril assembly (GO:0055003) | 5.80604187 |
| 6 | skeletal muscle contraction (GO:0003009) | 5.40667461 |
| 7 | actin-mediated cell contraction (GO:0070252) | 5.38835702 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.28809605 |
| 9 | plasma membrane repair (GO:0001778) | 5.20379902 |
| 10 | skeletal muscle adaptation (GO:0043501) | 5.15999231 |
| 11 | cardiac muscle hypertrophy (GO:0003300) | 4.98986135 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.77485542 |
| 13 | striated muscle hypertrophy (GO:0014897) | 4.74028567 |
| 14 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.67115101 |
| 15 | actin filament-based movement (GO:0030048) | 4.23819987 |
| 16 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.23770253 |
| 17 | muscle hypertrophy (GO:0014896) | 4.23589904 |
| 18 | creatine metabolic process (GO:0006600) | 4.23315750 |
| 19 | skeletal muscle fiber development (GO:0048741) | 4.14638867 |
| 20 | regulation of cell communication by electrical coupling (GO:0010649) | 4.12227463 |
| 21 | glycogen catabolic process (GO:0005980) | 4.11950496 |
| 22 | cardiac muscle cell development (GO:0055013) | 3.94120462 |
| 23 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.89083438 |
| 24 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.87379665 |
| 25 | glucan catabolic process (GO:0009251) | 3.85977953 |
| 26 | adult heart development (GO:0007512) | 3.84982798 |
| 27 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.79739476 |
| 28 | cardiac cell development (GO:0055006) | 3.76338927 |
| 29 | striated muscle contraction (GO:0006941) | 3.71911004 |
| 30 | muscle contraction (GO:0006936) | 3.71483423 |
| 31 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.71345478 |
| 32 | muscle hypertrophy in response to stress (GO:0003299) | 3.71345478 |
| 33 | cardiac muscle adaptation (GO:0014887) | 3.71345478 |
| 34 | carnitine shuttle (GO:0006853) | 3.70059275 |
| 35 | regulation of the force of heart contraction (GO:0002026) | 3.69849510 |
| 36 | sarcomere organization (GO:0045214) | 3.68849765 |
| 37 | muscle tissue morphogenesis (GO:0060415) | 3.63919565 |
| 38 | NADH metabolic process (GO:0006734) | 3.59821872 |
| 39 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.57913155 |
| 40 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.53006014 |
| 41 | myotube cell development (GO:0014904) | 3.52262108 |
| 42 | cellular polysaccharide catabolic process (GO:0044247) | 3.51778057 |
| 43 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.43612289 |
| 44 | regulation of myoblast differentiation (GO:0045661) | 3.38582821 |
| 45 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.37255094 |
| 46 | skeletal muscle tissue development (GO:0007519) | 3.36683633 |
| 47 | polysaccharide catabolic process (GO:0000272) | 3.34693695 |
| 48 | striated muscle cell development (GO:0055002) | 3.32717781 |
| 49 | muscle system process (GO:0003012) | 3.30765333 |
| 50 | cellular response to epinephrine stimulus (GO:0071872) | 3.30157315 |
| 51 | myofibril assembly (GO:0030239) | 3.29338826 |
| 52 | neurofilament cytoskeleton organization (GO:0060052) | 3.27826630 |
| 53 | neuromuscular synaptic transmission (GO:0007274) | 3.27761319 |
| 54 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.26556280 |
| 55 | cGMP-mediated signaling (GO:0019934) | 3.26325676 |
| 56 | cell communication by electrical coupling (GO:0010644) | 3.26294359 |
| 57 | response to epinephrine (GO:0071871) | 3.25403839 |
| 58 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.22520818 |
| 59 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.22520818 |
| 60 | membrane depolarization during action potential (GO:0086010) | 3.20356512 |
| 61 | muscle organ development (GO:0007517) | 3.17290662 |
| 62 | response to inactivity (GO:0014854) | 3.17147920 |
| 63 | muscle structure development (GO:0061061) | 3.15609320 |
| 64 | potassium ion import (GO:0010107) | 3.15283252 |
| 65 | muscle fiber development (GO:0048747) | 3.14906737 |
| 66 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.13260468 |
| 67 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.11897001 |
| 68 | relaxation of cardiac muscle (GO:0055119) | 3.11043522 |
| 69 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.07068002 |
| 70 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.06751232 |
| 71 | cellular potassium ion homeostasis (GO:0030007) | 3.03855211 |
| 72 | fatty acid transmembrane transport (GO:1902001) | 3.02921619 |
| 73 | striated muscle atrophy (GO:0014891) | 3.02007380 |
| 74 | hypotonic response (GO:0006971) | 3.01358708 |
| 75 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.97841630 |
| 76 | muscle cell development (GO:0055001) | 2.97213066 |
| 77 | glycogen biosynthetic process (GO:0005978) | 2.97084977 |
| 78 | glucan biosynthetic process (GO:0009250) | 2.97084977 |
| 79 | muscle adaptation (GO:0043500) | 2.96960949 |
| 80 | response to muscle activity (GO:0014850) | 2.96253048 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.95993697 |
| 82 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.95672457 |
| 83 | actomyosin structure organization (GO:0031032) | 2.94215518 |
| 84 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.87032939 |
| 85 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.87032939 |
| 86 | regulation of cardiac muscle contraction (GO:0055117) | 2.86977952 |
| 87 | cardiac muscle cell action potential (GO:0086001) | 2.86059381 |
| 88 | potassium ion homeostasis (GO:0055075) | 2.83672321 |
| 89 | regulation of skeletal muscle fiber development (GO:0048742) | 2.83226319 |
| 90 | striated muscle adaptation (GO:0014888) | 2.82349777 |
| 91 | muscle cell fate commitment (GO:0042693) | 2.81992472 |
| 92 | neuronal action potential (GO:0019228) | 2.81127955 |
| 93 | regulation of membrane repolarization (GO:0060306) | 2.78761837 |
| 94 | regulation of heart contraction (GO:0008016) | 2.77887910 |
| 95 | 2-oxoglutarate metabolic process (GO:0006103) | 2.77765618 |
| 96 | regulation of actin filament-based movement (GO:1903115) | 2.77537686 |
| 97 | muscle cell cellular homeostasis (GO:0046716) | 2.77394311 |
| 98 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.77394112 |
| 99 | glycogen metabolic process (GO:0005977) | 2.76700804 |
| 100 | carnitine transmembrane transport (GO:1902603) | 2.74379062 |
| 101 | positive regulation of potassium ion transport (GO:0043268) | 2.72345164 |
| 102 | glucan metabolic process (GO:0044042) | 2.71231455 |
| 103 | cellular glucan metabolic process (GO:0006073) | 2.71231455 |
| 104 | regulation of relaxation of muscle (GO:1901077) | 2.69371745 |
| 105 | neuromuscular junction development (GO:0007528) | 2.66463778 |
| 106 | regulation of striated muscle contraction (GO:0006942) | 2.66304820 |
| 107 | relaxation of muscle (GO:0090075) | 2.63368244 |
| 108 | negative regulation of protein localization to cell surface (GO:2000009) | 2.62854803 |
| 109 | regulation of cation channel activity (GO:2001257) | 2.60186966 |
| 110 | sodium ion export (GO:0071436) | 2.59927806 |
| 111 | cardiac muscle contraction (GO:0060048) | 2.57918523 |
| 112 | synaptic vesicle maturation (GO:0016188) | 2.57742024 |
| 113 | positive regulation of cation channel activity (GO:2001259) | 2.56754410 |
| 114 | endoplasmic reticulum organization (GO:0007029) | 2.56663537 |
| 115 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.56568028 |
| 116 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.55357901 |
| 117 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.53163056 |
| 118 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.52706729 |
| 119 | axon ensheathment in central nervous system (GO:0032291) | 2.51338897 |
| 120 | central nervous system myelination (GO:0022010) | 2.51338897 |
| 121 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.51117374 |
| 122 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.50971022 |
| 123 | muscle atrophy (GO:0014889) | 2.50594685 |
| 124 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.49030263 |
| 125 | carnitine transport (GO:0015879) | 2.46862705 |
| 126 | amino-acid betaine transport (GO:0015838) | 2.46862705 |
| 127 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.45278845 |
| 128 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.44827767 |
| 129 | detection of temperature stimulus (GO:0016048) | 2.43744353 |
| 130 | regulation of muscle system process (GO:0090257) | 2.41436191 |
| 131 | establishment of mitochondrion localization (GO:0051654) | 2.40318751 |
| 132 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.39017367 |
| 133 | activation of protein kinase A activity (GO:0034199) | 2.38061070 |
| 134 | negative regulation of muscle hypertrophy (GO:0014741) | 2.37817245 |
| 135 | cell communication involved in cardiac conduction (GO:0086065) | 2.37520698 |
| 136 | regulation of muscle contraction (GO:0006937) | 2.35585586 |
| 137 | regulation of synapse structural plasticity (GO:0051823) | 2.32457359 |
| 138 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.32064323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.06415360 |
| 2 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.39556779 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.31967886 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.29875627 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.26297933 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.19431277 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.19431277 |
| 8 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.15667198 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13177535 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.11293020 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.10782608 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.08658633 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.05550943 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.93981668 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.86861198 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86708847 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.83925774 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82247665 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.79670949 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.76871869 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.76095961 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.72345954 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69455238 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68565266 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.68098437 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.66692626 |
| 27 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.64930794 |
| 28 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.62915910 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.62734681 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62533276 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.54577284 |
| 32 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.51552072 |
| 33 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.50313900 |
| 34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.49427280 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43650825 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41831282 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.40048600 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35529203 |
| 39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35304035 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33424917 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31383469 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30299615 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.29563910 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26277861 |
| 45 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25647825 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23006199 |
| 47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.22842159 |
| 48 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18608847 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18096063 |
| 50 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.18048440 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17264734 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16088276 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15949878 |
| 54 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15834834 |
| 55 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15439663 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15260551 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14972636 |
| 58 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14089872 |
| 59 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.13309143 |
| 60 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.13185365 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12642200 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11839283 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11839283 |
| 64 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.11163428 |
| 65 | KDM2B_26808549_Chip-Seq_K562_Human | 1.11000127 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09741650 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08422161 |
| 68 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07904121 |
| 69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07904121 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05365536 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05350478 |
| 72 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04404707 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04320689 |
| 74 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03585700 |
| 75 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.03414360 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03041191 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02961660 |
| 78 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.02239754 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.01972014 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01168694 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01145409 |
| 82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00506702 |
| 83 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99929767 |
| 84 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.99533044 |
| 85 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98575134 |
| 86 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98567673 |
| 87 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.98077715 |
| 88 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97993485 |
| 89 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97936013 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97752787 |
| 91 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.97301689 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97004793 |
| 93 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.96586154 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96096408 |
| 95 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.95815126 |
| 96 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95667086 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95543337 |
| 98 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95045092 |
| 99 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94453147 |
| 100 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.94399174 |
| 101 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94262371 |
| 102 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92741878 |
| 103 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92129571 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91852738 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91378047 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90956486 |
| 107 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90587858 |
| 108 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90092860 |
| 109 | AR_19668381_ChIP-Seq_PC3_Human | 0.88920693 |
| 110 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.88801759 |
| 111 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88746824 |
| 112 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87400318 |
| 113 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87106015 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86936192 |
| 115 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86480115 |
| 116 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86277967 |
| 117 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86251743 |
| 118 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86076849 |
| 119 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85238422 |
| 120 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85104512 |
| 121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85045816 |
| 122 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.84998306 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84885732 |
| 124 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84755041 |
| 125 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84291098 |
| 126 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84128099 |
| 127 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84057075 |
| 128 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.83725321 |
| 129 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83680109 |
| 130 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83462117 |
| 131 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81203241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 5.87273389 |
| 2 | MP0000751_myopathy | 4.75338784 |
| 3 | MP0000749_muscle_degeneration | 4.60972451 |
| 4 | MP0003646_muscle_fatigue | 3.92773945 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.51749333 |
| 6 | MP0000747_muscle_weakness | 3.48408446 |
| 7 | MP0004270_analgesia | 3.24174283 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.07026920 |
| 9 | MP0002106_abnormal_muscle_physiology | 2.80475133 |
| 10 | MP0000759_abnormal_skeletal_muscle | 2.64799653 |
| 11 | MP0005620_abnormal_muscle_contractility | 2.61868604 |
| 12 | MP0004130_abnormal_muscle_cell | 2.53999621 |
| 13 | MP0004087_abnormal_muscle_fiber | 2.46534462 |
| 14 | MP0005369_muscle_phenotype | 2.43073112 |
| 15 | MP0002269_muscular_atrophy | 2.38406564 |
| 16 | MP0005670_abnormal_white_adipose | 2.37391729 |
| 17 | MP0004510_myositis | 2.37032204 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.26517210 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.26403783 |
| 20 | MP0000750_abnormal_muscle_regeneration | 2.19819675 |
| 21 | MP0004858_abnormal_nervous_system | 2.05519345 |
| 22 | MP0005451_abnormal_body_composition | 1.99026394 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.96953644 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 1.85544992 |
| 25 | MP0004147_increased_porphyrin_level | 1.81769968 |
| 26 | MP0004233_abnormal_muscle_weight | 1.77381490 |
| 27 | MP0002736_abnormal_nociception_after | 1.73647097 |
| 28 | MP0002108_abnormal_muscle_morphology | 1.67303085 |
| 29 | MP0002127_abnormal_cardiovascular_syste | 1.66682733 |
| 30 | MP0005330_cardiomyopathy | 1.62804436 |
| 31 | MP0002332_abnormal_exercise_endurance | 1.55021964 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.49250751 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 1.48277001 |
| 34 | MP0004484_altered_response_of | 1.44327970 |
| 35 | MP0003329_amyloid_beta_deposits | 1.42790166 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.40027277 |
| 37 | MP0000733_abnormal_muscle_development | 1.39141125 |
| 38 | MP0010386_abnormal_urinary_bladder | 1.35145429 |
| 39 | MP0001299_abnormal_eye_distance/ | 1.31517644 |
| 40 | MP0004215_abnormal_myocardial_fiber | 1.31366027 |
| 41 | MP0003635_abnormal_synaptic_transmissio | 1.30796028 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.30240877 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.29592668 |
| 44 | MP0001970_abnormal_pain_threshold | 1.28811549 |
| 45 | MP0002972_abnormal_cardiac_muscle | 1.26683149 |
| 46 | MP0003950_abnormal_plasma_membrane | 1.17577827 |
| 47 | MP0002272_abnormal_nervous_system | 1.17037970 |
| 48 | MP0001661_extended_life_span | 1.13753559 |
| 49 | MP0008569_lethality_at_weaning | 1.12812517 |
| 50 | MP0003880_abnormal_central_pattern | 1.12725303 |
| 51 | MP0003045_fibrosis | 1.10844037 |
| 52 | MP0005275_abnormal_skin_tensile | 1.09637124 |
| 53 | MP0005666_abnormal_adipose_tissue | 1.09587105 |
| 54 | MP0010368_abnormal_lymphatic_system | 1.03317607 |
| 55 | MP0000920_abnormal_myelination | 1.03141761 |
| 56 | MP0003879_abnormal_hair_cell | 1.02734515 |
| 57 | MP0005266_abnormal_metabolism | 1.01797593 |
| 58 | MP0009046_muscle_twitch | 1.00099165 |
| 59 | MP0002067_abnormal_sensory_capabilities | 0.98573547 |
| 60 | MP0006276_abnormal_autonomic_nervous | 0.97167136 |
| 61 | MP0001440_abnormal_grooming_behavior | 0.97027212 |
| 62 | MP0003828_pulmonary_edema | 0.95817266 |
| 63 | MP0009745_abnormal_behavioral_response | 0.91798125 |
| 64 | MP0005623_abnormal_meninges_morphology | 0.91520203 |
| 65 | MP0002064_seizures | 0.91250857 |
| 66 | MP0000534_abnormal_ureter_morphology | 0.90337153 |
| 67 | MP0005375_adipose_tissue_phenotype | 0.90234774 |
| 68 | MP0000955_abnormal_spinal_cord | 0.89604993 |
| 69 | MP0003633_abnormal_nervous_system | 0.87234412 |
| 70 | MP0002063_abnormal_learning/memory/cond | 0.86716880 |
| 71 | MP0001664_abnormal_digestion | 0.85492563 |
| 72 | MP0002184_abnormal_innervation | 0.85114615 |
| 73 | MP0003137_abnormal_impulse_conducting | 0.85012037 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 0.84515203 |
| 75 | MP0004134_abnormal_chest_morphology | 0.82675733 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.82468402 |
| 77 | MP0000462_abnormal_digestive_system | 0.82394037 |
| 78 | MP0001486_abnormal_startle_reflex | 0.81499175 |
| 79 | MP0004043_abnormal_pH_regulation | 0.81307098 |
| 80 | MP0004272_abnormal_basement_membrane | 0.80764567 |
| 81 | MP0005367_renal/urinary_system_phenotyp | 0.78913937 |
| 82 | MP0000516_abnormal_urinary_system | 0.78913937 |
| 83 | MP0009250_abnormal_appendicular_skeleto | 0.76977403 |
| 84 | MP0000266_abnormal_heart_morphology | 0.76241172 |
| 85 | MP0010630_abnormal_cardiac_muscle | 0.74727172 |
| 86 | MP0005423_abnormal_somatic_nervous | 0.74248035 |
| 87 | MP0004085_abnormal_heartbeat | 0.74205860 |
| 88 | MP0000762_abnormal_tongue_morphology | 0.73775885 |
| 89 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73574909 |
| 90 | MP0006036_abnormal_mitochondrial_physio | 0.73200664 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.70823619 |
| 92 | MP0005165_increased_susceptibility_to | 0.70731458 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.70618349 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.70601109 |
| 95 | MP0002066_abnormal_motor_capabilities/c | 0.70486392 |
| 96 | MP0005385_cardiovascular_system_phenoty | 0.69058739 |
| 97 | MP0001544_abnormal_cardiovascular_syste | 0.69058739 |
| 98 | MP0002971_abnormal_brown_adipose | 0.68969844 |
| 99 | MP0004811_abnormal_neuron_physiology | 0.68504856 |
| 100 | MP0005409_darkened_coat_color | 0.68021402 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.66985177 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.66154342 |
| 103 | MP0008004_abnormal_stomach_pH | 0.66141511 |
| 104 | MP0003634_abnormal_glial_cell | 0.66121026 |
| 105 | MP0003631_nervous_system_phenotype | 0.66094206 |
| 106 | MP0006138_congestive_heart_failure | 0.65142534 |
| 107 | MP0000538_abnormal_urinary_bladder | 0.64498189 |
| 108 | MP0001270_distended_abdomen | 0.64371128 |
| 109 | MP0002822_catalepsy | 0.64362492 |
| 110 | MP0000778_abnormal_nervous_system | 0.64063382 |
| 111 | MP0002128_abnormal_blood_circulation | 0.62704499 |
| 112 | MP0002882_abnormal_neuron_morphology | 0.62610574 |
| 113 | MP0001984_abnormal_olfaction | 0.61838961 |
| 114 | MP0001879_abnormal_lymphatic_vessel | 0.61306263 |
| 115 | MP0003279_aneurysm | 0.61061717 |
| 116 | MP0001958_emphysema | 0.60528159 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.60423094 |
| 118 | MP0002229_neurodegeneration | 0.59740106 |
| 119 | MP0008775_abnormal_heart_ventricle | 0.58649142 |
| 120 | MP0002638_abnormal_pupillary_reflex | 0.58407642 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.57599073 |
| 122 | MP0002572_abnormal_emotion/affect_behav | 0.56833507 |
| 123 | MP0008438_abnormal_cutaneous_collagen | 0.55242610 |
| 124 | MP0001502_abnormal_circadian_rhythm | 0.51974335 |
| 125 | MP0005503_abnormal_tendon_morphology | 0.51886439 |
| 126 | MP0005171_absent_coat_pigmentation | 0.48012077 |
| 127 | MP0005166_decreased_susceptibility_to | 0.46431845 |
| 128 | MP0003091_abnormal_cell_migration | 0.45854959 |
| 129 | MP0002896_abnormal_bone_mineralization | 0.44356335 |
| 130 | MP0009115_abnormal_fat_cell | 0.44134229 |
| 131 | MP0005187_abnormal_penis_morphology | 0.44122679 |
| 132 | MP0002078_abnormal_glucose_homeostasis | 0.42954710 |
| 133 | MP0000343_altered_response_to | 0.41653795 |
| 134 | MP0003806_abnormal_nucleotide_metabolis | 0.39927661 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.37943876 |
| 136 | MP0003690_abnormal_glial_cell | 0.36840850 |
| 137 | MP0005334_abnormal_fat_pad | 0.36698366 |
| 138 | MP0001501_abnormal_sleep_pattern | 0.36362866 |
| 139 | MP0003948_abnormal_gas_homeostasis | 0.36062836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.63347921 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.35054266 |
| 3 | Exercise-induced myalgia (HP:0003738) | 7.01546650 |
| 4 | Nemaline bodies (HP:0003798) | 6.95143067 |
| 5 | Distal arthrogryposis (HP:0005684) | 6.50554288 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 6.12891347 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 6.09291448 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.57569375 |
| 9 | Myopathic facies (HP:0002058) | 5.39144707 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.34211914 |
| 11 | Round ear (HP:0100830) | 5.31998525 |
| 12 | Difficulty running (HP:0009046) | 5.14547874 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 4.89440387 |
| 14 | Muscle fiber splitting (HP:0003555) | 4.87533024 |
| 15 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.59583999 |
| 16 | Ulnar deviation of the wrist (HP:0003049) | 4.59121661 |
| 17 | Absent phalangeal crease (HP:0006109) | 4.37093547 |
| 18 | Muscle stiffness (HP:0003552) | 4.33641656 |
| 19 | Myotonia (HP:0002486) | 4.27970936 |
| 20 | Calcaneovalgus deformity (HP:0001848) | 4.04117671 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 3.85440096 |
| 22 | Myoglobinuria (HP:0002913) | 3.82033788 |
| 23 | Deformed tarsal bones (HP:0008119) | 3.75367886 |
| 24 | Increased connective tissue (HP:0009025) | 3.74972907 |
| 25 | Abnormal finger flexion creases (HP:0006143) | 3.73490455 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 3.59603280 |
| 27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.54495770 |
| 28 | Increased variability in muscle fiber diameter (HP:0003557) | 3.51965870 |
| 29 | Ventricular tachycardia (HP:0004756) | 3.40021170 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 3.24020910 |
| 31 | Facial diplegia (HP:0001349) | 3.23673189 |
| 32 | Lipoatrophy (HP:0100578) | 3.20561584 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 2.99365939 |
| 34 | Sudden death (HP:0001699) | 2.99086708 |
| 35 | Neck muscle weakness (HP:0000467) | 2.98033250 |
| 36 | Heart block (HP:0012722) | 2.94135409 |
| 37 | Difficulty climbing stairs (HP:0003551) | 2.86015717 |
| 38 | Abnormal atrioventricular conduction (HP:0005150) | 2.84843267 |
| 39 | Rhabdomyolysis (HP:0003201) | 2.80464987 |
| 40 | Scapular winging (HP:0003691) | 2.75047908 |
| 41 | Atrial fibrillation (HP:0005110) | 2.73835511 |
| 42 | Papilledema (HP:0001085) | 2.73150857 |
| 43 | Areflexia of lower limbs (HP:0002522) | 2.72499743 |
| 44 | Insidious onset (HP:0003587) | 2.71009385 |
| 45 | Termporal pattern (HP:0011008) | 2.71009385 |
| 46 | Rimmed vacuoles (HP:0003805) | 2.70170472 |
| 47 | Generalized muscle weakness (HP:0003324) | 2.68037255 |
| 48 | Foot dorsiflexor weakness (HP:0009027) | 2.60450610 |
| 49 | Ventricular arrhythmia (HP:0004308) | 2.58477629 |
| 50 | Hyperkalemia (HP:0002153) | 2.57624405 |
| 51 | Ulnar claw (HP:0001178) | 2.57483419 |
| 52 | Frequent falls (HP:0002359) | 2.56091856 |
| 53 | Syncope (HP:0001279) | 2.53366014 |
| 54 | Abnormality of the calcaneus (HP:0008364) | 2.49051057 |
| 55 | Primary atrial arrhythmia (HP:0001692) | 2.45780445 |
| 56 | Subaortic stenosis (HP:0001682) | 2.41248146 |
| 57 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.41248146 |
| 58 | Abnormality of the foot musculature (HP:0001436) | 2.38311209 |
| 59 | Aortic aneurysm (HP:0004942) | 2.36111436 |
| 60 | Supraventricular tachycardia (HP:0004755) | 2.35384365 |
| 61 | Increased density of long bones (HP:0006392) | 2.35168202 |
| 62 | Ankle clonus (HP:0011448) | 2.32187673 |
| 63 | Supraventricular arrhythmia (HP:0005115) | 2.31950696 |
| 64 | Asymmetric septal hypertrophy (HP:0001670) | 2.29608296 |
| 65 | EMG: neuropathic changes (HP:0003445) | 2.28777889 |
| 66 | Myokymia (HP:0002411) | 2.26882909 |
| 67 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.24883958 |
| 68 | Ventricular fibrillation (HP:0001663) | 2.24823174 |
| 69 | Atrioventricular block (HP:0001678) | 2.23281971 |
| 70 | Shoulder girdle muscle weakness (HP:0003547) | 2.22840176 |
| 71 | Weak cry (HP:0001612) | 2.21202615 |
| 72 | Distal lower limb muscle weakness (HP:0009053) | 2.19878998 |
| 73 | Stridor (HP:0010307) | 2.14178034 |
| 74 | Ulnar deviation of finger (HP:0009465) | 2.13970303 |
| 75 | Urinary urgency (HP:0000012) | 2.13622021 |
| 76 | Muscular dystrophy (HP:0003560) | 2.10679224 |
| 77 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.09237709 |
| 78 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.09237709 |
| 79 | Hip contracture (HP:0003273) | 2.08728613 |
| 80 | Achilles tendon contracture (HP:0001771) | 2.07081089 |
| 81 | Malignant hyperthermia (HP:0002047) | 2.06063764 |
| 82 | Proximal amyotrophy (HP:0007126) | 2.05008666 |
| 83 | Steppage gait (HP:0003376) | 2.04242821 |
| 84 | Nuclear cataract (HP:0100018) | 2.04204856 |
| 85 | Gowers sign (HP:0003391) | 2.03003780 |
| 86 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.02438429 |
| 87 | Prolonged QT interval (HP:0001657) | 2.01321671 |
| 88 | Spinal rigidity (HP:0003306) | 2.01103506 |
| 89 | Focal motor seizures (HP:0011153) | 1.99770824 |
| 90 | Pelvic girdle muscle weakness (HP:0003749) | 1.99556417 |
| 91 | Waddling gait (HP:0002515) | 1.99322393 |
| 92 | Slender build (HP:0001533) | 1.97879331 |
| 93 | Action tremor (HP:0002345) | 1.95794933 |
| 94 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.93694698 |
| 95 | Pheochromocytoma (HP:0002666) | 1.89160433 |
| 96 | Limb-girdle muscle atrophy (HP:0003797) | 1.88750158 |
| 97 | Limb-girdle muscle weakness (HP:0003325) | 1.85069334 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 1.80309698 |
| 99 | Hypoplastic ischia (HP:0003175) | 1.78946382 |
| 100 | Paralysis (HP:0003470) | 1.78405555 |
| 101 | Abnormality of the ischium (HP:0003174) | 1.78280643 |
| 102 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.75966574 |
| 103 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.75966574 |
| 104 | Supranuclear gaze palsy (HP:0000605) | 1.75541350 |
| 105 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.74442299 |
| 106 | Tarsal synostosis (HP:0008368) | 1.73982415 |
| 107 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.70447399 |
| 108 | Abnormality of the corticospinal tract (HP:0002492) | 1.70062125 |
| 109 | Fetal akinesia sequence (HP:0001989) | 1.69813902 |
| 110 | Abnormal EKG (HP:0003115) | 1.69455246 |
| 111 | Ragged-red muscle fibers (HP:0003200) | 1.69019535 |
| 112 | Abnormality of the neuromuscular junction (HP:0003398) | 1.68134004 |
| 113 | Fatigable weakness (HP:0003473) | 1.68134004 |
| 114 | Aortic dissection (HP:0002647) | 1.68088304 |
| 115 | Dysmetric saccades (HP:0000641) | 1.67975735 |
| 116 | Limited hip movement (HP:0008800) | 1.67637111 |
| 117 | Distal lower limb amyotrophy (HP:0008944) | 1.66040569 |
| 118 | Rapidly progressive (HP:0003678) | 1.65845360 |
| 119 | Nonprogressive disorder (HP:0003680) | 1.65448366 |
| 120 | Bundle branch block (HP:0011710) | 1.64903757 |
| 121 | Onion bulb formation (HP:0003383) | 1.64510573 |
| 122 | Lower limb amyotrophy (HP:0007210) | 1.64223347 |
| 123 | Bulbar palsy (HP:0001283) | 1.63938741 |
| 124 | Diaphragmatic weakness (HP:0009113) | 1.62739352 |
| 125 | Lower limb muscle weakness (HP:0007340) | 1.60450613 |
| 126 | Congenital hip dislocation (HP:0001374) | 1.59738174 |
| 127 | Palpitations (HP:0001962) | 1.54586860 |
| 128 | Obstructive sleep apnea (HP:0002870) | 1.54143752 |
| 129 | Resting tremor (HP:0002322) | 1.52154526 |
| 130 | Cerebral aneurysm (HP:0004944) | 1.49664319 |
| 131 | Progressive muscle weakness (HP:0003323) | 1.44942609 |
| 132 | Difficulty walking (HP:0002355) | 1.43850697 |
| 133 | Left ventricular hypertrophy (HP:0001712) | 1.39963792 |
| 134 | Metatarsus adductus (HP:0001840) | 1.38392971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.16115576 |
| 2 | PHKG1 | 4.78648917 |
| 3 | PHKG2 | 4.78648917 |
| 4 | OBSCN | 4.76769359 |
| 5 | PIK3CG | 2.70709762 |
| 6 | NME1 | 2.59355075 |
| 7 | MYLK | 2.50845778 |
| 8 | DMPK | 2.47372739 |
| 9 | LMTK2 | 2.29531738 |
| 10 | STK39 | 2.07961876 |
| 11 | KSR2 | 1.89934940 |
| 12 | MAP2K4 | 1.82163519 |
| 13 | MAP3K9 | 1.73010941 |
| 14 | NTRK3 | 1.64297612 |
| 15 | NTRK1 | 1.63930546 |
| 16 | PIK3CA | 1.54597952 |
| 17 | EEF2K | 1.51490168 |
| 18 | MINK1 | 1.50456212 |
| 19 | PINK1 | 1.47263283 |
| 20 | LIMK1 | 1.45329345 |
| 21 | MAP3K2 | 1.42741055 |
| 22 | MAP3K7 | 1.42563575 |
| 23 | PDK4 | 1.33890306 |
| 24 | PDK3 | 1.33890306 |
| 25 | LATS2 | 1.33086129 |
| 26 | MAP2K3 | 1.23613327 |
| 27 | MAPKAPK3 | 1.19176263 |
| 28 | PDK2 | 1.15085433 |
| 29 | PAK6 | 1.10808287 |
| 30 | TRIB3 | 1.09682105 |
| 31 | MAPK12 | 1.08869327 |
| 32 | EPHB1 | 1.05549996 |
| 33 | NEK1 | 1.02833563 |
| 34 | WNK1 | 1.02101514 |
| 35 | CAMK2G | 1.01646161 |
| 36 | MAP3K4 | 1.01319878 |
| 37 | RET | 1.00582652 |
| 38 | PNCK | 0.99049002 |
| 39 | LATS1 | 0.97871720 |
| 40 | MAP3K13 | 0.97817100 |
| 41 | MAP2K6 | 0.96686178 |
| 42 | FER | 0.96482776 |
| 43 | MOS | 0.91896392 |
| 44 | AKT3 | 0.90628926 |
| 45 | MARK1 | 0.88587185 |
| 46 | SGK2 | 0.88185720 |
| 47 | MARK3 | 0.86435702 |
| 48 | ICK | 0.85960264 |
| 49 | MAPKAPK5 | 0.84699506 |
| 50 | SGK3 | 0.83133821 |
| 51 | RIPK1 | 0.82800101 |
| 52 | PAK2 | 0.80197968 |
| 53 | OXSR1 | 0.74522269 |
| 54 | CAMK4 | 0.74196498 |
| 55 | DDR2 | 0.71815930 |
| 56 | ROCK1 | 0.71505701 |
| 57 | NEK9 | 0.71110222 |
| 58 | ROCK2 | 0.69453418 |
| 59 | MAP2K1 | 0.69245788 |
| 60 | MARK2 | 0.69152699 |
| 61 | TIE1 | 0.67329224 |
| 62 | WNK4 | 0.66527703 |
| 63 | FGFR2 | 0.66482324 |
| 64 | MAPK4 | 0.65061853 |
| 65 | PRKD3 | 0.64465316 |
| 66 | MAPK7 | 0.63658681 |
| 67 | GRK5 | 0.63313801 |
| 68 | CAMK1G | 0.62812395 |
| 69 | MAP3K1 | 0.62076089 |
| 70 | EPHA3 | 0.61387209 |
| 71 | RPS6KA2 | 0.61241027 |
| 72 | MTOR | 0.60476426 |
| 73 | PAK3 | 0.59795223 |
| 74 | PTK2B | 0.58098123 |
| 75 | SGK223 | 0.56654940 |
| 76 | SGK494 | 0.56654940 |
| 77 | PDGFRA | 0.55505540 |
| 78 | CDK5 | 0.55412454 |
| 79 | PKN1 | 0.51906566 |
| 80 | PRKAA2 | 0.51695515 |
| 81 | MAP3K12 | 0.51600962 |
| 82 | PDPK1 | 0.51573857 |
| 83 | AKT2 | 0.51212155 |
| 84 | STK38L | 0.50986304 |
| 85 | PRKAA1 | 0.50756901 |
| 86 | PRKACB | 0.50498323 |
| 87 | CAMK2D | 0.50489819 |
| 88 | DAPK2 | 0.50057907 |
| 89 | BCKDK | 0.49899191 |
| 90 | CDC42BPA | 0.48475452 |
| 91 | TRPM7 | 0.48281092 |
| 92 | MUSK | 0.48172933 |
| 93 | MAPK13 | 0.47815515 |
| 94 | FRK | 0.44854939 |
| 95 | CCNB1 | 0.44367725 |
| 96 | SGK1 | 0.43816483 |
| 97 | PRKD1 | 0.43729280 |
| 98 | TAOK1 | 0.42810769 |
| 99 | STK38 | 0.42196847 |
| 100 | CAMK2A | 0.41228889 |
| 101 | MAPK10 | 0.40796295 |
| 102 | MAPK15 | 0.40512577 |
| 103 | CAMK2B | 0.39770472 |
| 104 | MAP2K2 | 0.37843898 |
| 105 | MET | 0.37389448 |
| 106 | PDK1 | 0.37315947 |
| 107 | ILK | 0.36312399 |
| 108 | PRKG1 | 0.36081022 |
| 109 | RPS6KB1 | 0.35159566 |
| 110 | EPHA4 | 0.32692179 |
| 111 | RPS6KA3 | 0.32601965 |
| 112 | GSK3A | 0.32532645 |
| 113 | NLK | 0.31814390 |
| 114 | SIK1 | 0.31493495 |
| 115 | MAPK11 | 0.30896317 |
| 116 | MAP3K6 | 0.30857396 |
| 117 | MAP2K7 | 0.30454540 |
| 118 | PRKCH | 0.30335297 |
| 119 | ARAF | 0.29758966 |
| 120 | TNK2 | 0.29375993 |
| 121 | PRPF4B | 0.28792133 |
| 122 | PTK2 | 0.28547105 |
| 123 | TGFBR2 | 0.28152436 |
| 124 | RPS6KC1 | 0.28073037 |
| 125 | RPS6KL1 | 0.28073037 |
| 126 | CAMK1 | 0.27659759 |
| 127 | PRKACA | 0.27140170 |
| 128 | TYRO3 | 0.26518536 |
| 129 | RPS6KA1 | 0.25432327 |
| 130 | UHMK1 | 0.24957037 |
| 131 | PKN2 | 0.20647840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.46464629 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.31774216 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.20353381 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.15016474 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.14669413 |
| 6 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.06137930 |
| 7 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.03806102 |
| 8 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.92189035 |
| 9 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.89827042 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.70769351 |
| 11 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.62554597 |
| 12 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.56125906 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 1.55060708 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.45990449 |
| 15 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45128832 |
| 16 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.43304344 |
| 17 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.42090722 |
| 18 | Tight junction_Homo sapiens_hsa04530 | 1.39715221 |
| 19 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38946337 |
| 20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.38330312 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37777060 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37623818 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.33269335 |
| 24 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.32781339 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.32479568 |
| 26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32190812 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31525453 |
| 28 | Long-term potentiation_Homo sapiens_hsa04720 | 1.31396557 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.28984067 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.28321811 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.21168914 |
| 32 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.21149186 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.19181602 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.17713758 |
| 35 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17109776 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.13203365 |
| 37 | GABAergic synapse_Homo sapiens_hsa04727 | 1.13061117 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12252386 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 1.11449313 |
| 40 | Insulin resistance_Homo sapiens_hsa04931 | 1.10756320 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06897980 |
| 42 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.06166706 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.05091618 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.01821672 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.01565121 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01398789 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00240721 |
| 48 | Gap junction_Homo sapiens_hsa04540 | 0.99826833 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98339688 |
| 50 | Circadian rhythm_Homo sapiens_hsa04710 | 0.97490704 |
| 51 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.96917382 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96115758 |
| 53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94636989 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.92616834 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 0.90907583 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.90486497 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.87333563 |
| 58 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.84877032 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84607633 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84015036 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.83339677 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83173427 |
| 63 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82501784 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82361842 |
| 65 | Taste transduction_Homo sapiens_hsa04742 | 0.81892007 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81889800 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81342122 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80079996 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.79862105 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78572244 |
| 71 | Morphine addiction_Homo sapiens_hsa05032 | 0.78213395 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75723258 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74718149 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.74691014 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73751479 |
| 76 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72429575 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71907429 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.69219082 |
| 79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68941108 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68564161 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.67027308 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66862826 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66793083 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65391894 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65231552 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.65176568 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.64143700 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63922973 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62242561 |
| 90 | Nicotine addiction_Homo sapiens_hsa05033 | 0.61623826 |
| 91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59282127 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58184675 |
| 93 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57595482 |
| 94 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.57460954 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56947328 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56540705 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56053726 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55678558 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54843258 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54277466 |
| 101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53547836 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52666757 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51784064 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51472630 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51261327 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.51233666 |
| 107 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48571416 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48413584 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48101922 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.47787826 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46870819 |
| 112 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46476578 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.46052405 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45350525 |
| 115 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45321547 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45207380 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44819660 |
| 118 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43120310 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39766065 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38198482 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37204971 |
| 122 | Cocaine addiction_Homo sapiens_hsa05030 | 0.35318947 |
| 123 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.34105188 |

